Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone relapse prevention discontinuation study in children and adolescents with conduct disorder
2010-021884-34Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in conduct disorder (CD) comparing Continued risperidone with Placebo after risperidone lead-in (2 arms). Primary endpoints: Primary efficacy endpoint and Primary discontinuation-phase efficacy assessment. Started Apr 2012; status: completed.
02
Drugs
risperidone
03
Conditions
conduct disorder (CD)
Beyond the preview
Go deeper on 2010-021884-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021884-34.